Clinical Trial Update: A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

View source ↗

Summary

A completed clinical trial evaluating afatinib following pembrolizumab and chemotherapy in metastatic squamous cell carcinoma of the lung; results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Afatinib (Gilotrif) (afatinib)
• Chemotherapy (chemotherapy)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Squamous Non-small Cell Lung Cancer | Status: COMPLETED | Results posted: 2021-07-08